Task: Answer the multiple-choice question.
Question: Which drug exhibits a 19.450% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a Cc1[nH]c(=S)[nH]c(=O)c1Cc1ccccc1
b Cc1cc(C(=O)Oc2ccccc2C(=O)O)c(C)o1
c CCC(C)n1[nH]c(=O)cc1N
d COC(=O)CSc1nnc(-c2ccc(OC)cc2OC)o1
e Cc1nc2nc(-c3ccco3)nn2c(C)c1Cl
Answer: c. CCC(C)n1[nH]c(=O)cc1N
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)n1[nH]c(=O)cc1N
CCC(C)n1[nH]c(=O)cc1N
3-amino-2-butan-2-yl-1H-pyrazol-5-one